Essayan, D M <br/><br/>
Differential efficacy of lymphocyte- and monocyte-selective pretreatment with a type 4 phosphodiesterase inhibitor on antigen-driven proliferation and cytokine gene expression.  [electronic resource] 

 -  The Journal of allergy and clinical immunology  Jan 1997 
 - 28-37 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0091-6749 
<br/><br/><label>Standard No.: </label>10.1016/s0091-6749(97)70297-5  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>3',5'-Cyclic-AMP Phosphodiesterases<br/>Allergens--pharmacology<br/>Antigens--pharmacology<br/>Cells, Cultured<br/>Cyclic AMP--metabolism<br/>Cyclic Nucleotide Phosphodiesterases, Type 4<br/>Cytokines--biosynthesis<br/>Gene Expression--drug effects<br/>Humans<br/>Leukocytes, Mononuclear--drug effects<br/>Lymphocyte Activation--drug effects<br/>Lymphocytes--drug effects<br/>Phosphodiesterase Inhibitors--pharmacology<br/>Phosphoric Diester Hydrolases--drug effects<br/>Plant Proteins--pharmacology<br/>Pyrrolidinones--pharmacology<br/>Receptors, Cell Surface--metabolism<br/>Rolipram<br/>Tetanus Toxoid--pharmacology